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1. Introduction 
Research on the non-steroidal anti-inflammatory olive oil phenolic, (-)- decarboxymethyl 
ligstroside aglycone (more commonly known as oleocanthal) has supported speculation that 
this compound may confer some of the health benefits associated with the traditional 
Mediterranean diet. Oleocanthal elicits a peppery, stinging sensation at the back of the throat 
similar to that of the non-steroidal anti-inflammatory drug (NSAID), ibuprofen (Beauchamp et 
al., 2005) and this localized irritation is due to stimulation of the transient receptor potential 
cation channel A1 (TRPA1) (Peyrot des Gachons et al., 2011). The perceptual similarity 
between oleocanthal and ibuprofen spurred the hypothesis that these two compounds may 
possess similar pharmacological properties. Further investigation demonstrated that 
oleocanthal inhibits inflammation in the same way as ibuprofen, and moreover, is 
substantially more potent on a equimolar basis (Beauchamp et al., 2005). Subsequent studies 
have shown that oleocanthal exhibits various modes of action in reducing inflammatory-
related disease, including neuro-degenerative disease (Pitt et al., 2009, Li et al., 2009), joint-
degenerative disease (Iacono et al., 2010) and specific cancers (Elnagar et al., 2011). Therefore, 
long term consumption of extra virgin olive oil (EVOO) containing oleocanthal may contribute 
to the health benefits associated with the Mediterranean dietary pattern. This chapter 
summarizes the current knowledge on oleocanthal, in terms of its sensory and physiological 
properties, its extraction from the oil matrix and subsequent identification and quantification, 
and finally the factors that may influence the concentration of oleocanthal in EVOO.  
2. Olive oil, a hallmark of the Mediterranean diet 
The health benefits of following a Mediterranean eating pattern were first acknowledged in 
the Seven Countries Study (Keys, 1970). Thereafter over a period of 30 years, a number of 
investigators have reported that the Mediterranean diet is associated with low rates of 
degenerative diseases such as cardiovascular disease (CVD) (Estruch et al., 2006, Pitsavos et 
al., 2005), coronary heart disease (CHD) (Fung et al., 2009), stroke (Fung et al., 2009), certain 
types of cancers (La Vecchia, 2004, Dixon et al., 2007), diabetes (Martinez-Gonzalez et al., 
2008), Alzheimer’s disease (Scarmeas et al., 2009) and non-alcoholic fatty liver disease 
(Fraser et al., 2008). Research has also demonstrated that Mediterranean populations have 
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increased life expectancy (Hu, 2003, Visioli et al., 2005, Trichopoulou et al., 2005), reduced 
risk of developing disorders such as metabolic syndrome (Tortosa et al., 2007, Babio et al., 
2008) and have decreased levels of systematic inflammation (Dai et al., 2009, Fragopoulou et 
al., 2010, Panagiotakos et al., 2009).  
The traditional Mediterranean diet is defined as the pattern of eating observed in the olive 
growing areas of the Mediterranean region, namely Greece and Southern Italy in the 1960s. 
An integral component of this dietary pattern is the consumption of EVOO (Stark and 
Madar, 2002, Kok and Kromhout, 2004). EVOO, the pillar of Mediterranean recipes, is 
commonly incorporated into cooked dishes as well as in salads. Typically, the intake of 
EVOO ranges from 25 to 50 ml per day in the Mediterranean diet (Corona et al., 2009). 
Therefore, the apparent health benefits have been partially attributed to the dietary 
consumption of EVOO by Mediterranean populations. Figure 1 displays the Mediterranean 
diet pyramid featuring EVOO as a core component of this dietary pattern. 
 
Fig. 1. Food pyramid reflecting the traditional Mediterranean diet. As depicted, EVOO is an 
integral food component of this diet residing in the consume ‘daily’ food group. 
3. Olive oil phenolic compounds 
Historically, the health promoting properties of EVOO were attributed to the high 
concentration of monounsaturated fatty acids (MUFAs), in particular oleic acid, contained in 
EVOO. However other seed oils (i.e. sunflower, soybean, and rapeseed), which also contain 
high concentrations of oleic acid, do not exhibit the same health benefits as EVOO (López-
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Miranda et al., 2010, Harper et al., 2006, Aguilera et al., 2004). In addition to oleic acid, 
EVOO contains a minor, yet significant phenolic fraction that other seed oils lack and this 
fraction has generated much interest regarding its health promoting properties.  
Currently, 36 phenolic compounds have been identified in EVOO and studies (human, 
animal, in vivo and in vitro) have demonstrated that olive oil phenolics have positive effects 
on certain physiological parameters such as plasma lipoproteins, oxidative damage, 
inflammatory markers, platelet and cellular function, antimicrobial activity, and bone health 
(for review see (Cicerale et al., 2010)), possibly reducing the risk of chronic disease 
development. 
4. Discovery of oleocanthal 
The phenolic compound (-)- decarboxymethyl ligstroside aglycone  was first reported in 
EVOO by Montedoro et al. (Montedoro and Servili, 1993) in 1993 (Figure 2). A decade after 
its discovery, Andrewes and colleagues (Andrewes et al., 2003) reported that 
decarboxymethyl ligstroside aglycone was responsible for the throat irritation and 
pungency elicited by some EVOOs. In 2005, Beauchamp et al. (Beauchamp et al., 2005) 
confirmed that the phenolic compound, decarboxymethyl ligstroside aglycone was indeed 
responsible for the throat irritation elicited by EVOOs post-ingestion. This confirmation was 
carried out by isolating the compound from various EVOOs and measuring the throat 
irritation elicited. However, at that stage, there was a possibility that co-elution of a minor 
component or a mixture of components along with decarboxymethyl ligstroside aglycone 
may collectively cause the localized throat irritation. Therefore, the authors chemically 
synthesized decarboxymethyl ligstroside aglycone and dissolved it in non-irritating corn oil. 
Throat irritation elicited by the synthesized decarboxymethyl ligstroside aglycone was 
found to be dose-dependent on the concentration of this phenolic in corn oil and mimicked 
that of EVOO containing this compound naturally. Decarboxymethyl ligstroside aglycone 
was thus deemed the sole throat irritant in EVOO and was named oleocanthal (oleo for olive, 
canth for sting, and al for aldehyde) (Beauchamp et al., 2005).  
HO
O
O
CHO
CHO
 
Fig. 2. Oleocanthal structure 
5. Sensory properties of oleocanthal 
The intake of EVOO is often associated with a peppery sting that is localized to the 
oropharyngeal region in the oral cavity (Figure 3). There is wide inter-individual variation 
in sensitivity to oleocanthal which can range from a slight irritation in the throat, to an 
irritation that is strong enough to produce a cough in those highly sensitive. Of particular 
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interest is the spatial location of irritation produced by oleocanthal. Irritating, pungent 
compounds often aggravate all regions in the oral cavity rather than acting on one localized 
area (Peyrot des Gachons et al., 2011), which implies a sensory receptor specific to 
oleocanthal exists in the oropharyngeal region of the oral cavity. Recent investigations have 
indeed verified that the TRPA1 is the receptor linked to oleocanthal and the anatomical 
location of this receptor has been found in the oropharyngeal region of the oral cavity 
(Peyrot des Gachons et al., 2011).  
 
Fig. 3. Oleocanthal irritation occurs solely in the oropharyngeal region (area shaded in 
black) of the oral cavity.  
A large variability among subjects in the perceived irritation from oleocanthal has been 
noted (Cicerale et al., 2009a). Such individual variation in perception of oleocanthal may be 
related directly to the quantity of the TRPA1 receptor, as has been reported for  
other oral stimuli such as the bitter compounds: 6-n-propylthiouracil (PROP) and 
phenylthiocarbamide (PTC) (Hansen et al., 2006), which activate the TAS2R38 bitter receptor 
(Hayes et al., 2011). The important link between the perceptual aspects of oleocanthal and 
health benefits is the notion that variation in sensitivity to oleocanthal irritation may relate 
to potential differences in sensitivity to the anti-inflammatory action of this compound. 
However, further research is required to investigate this. 
6. Physiological properties of oleocanthal and its putative health benefits 
Research conducted by Beauchamp and colleagues (Beauchamp et al., 2005) demonstrated 
that oleocanthal inhibits cyclooxygenase (COX) enzymes in a dose-dependent manner, 
mimicking the anti-inflammatory action exerted by ibuprofen. Cyclooxygenase 1 and 2 
(COX 1 and COX 2) enzymes are responsible for the conversion of arachidonic acid to 
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prostaglandins and thromboxane which are produced in response to inflammatory or toxic 
stimuli. COX 1 and COX 2 can be harmful to the body. In particular, COX 2 has been 
implicated in the pathogenesis of several cancers in both human and animal studies (Harris 
et al., 2003, Boland et al., 2004, Subbaramaiah et al., 2002, Ristimäki et al., 2002), and may 
also play a role in atherosclerosis (Chenevard et al., 2003). The novel findings presented by 
Beauchamp and colleagues (Beauchamp et al., 2005) demonstrate that oleocanthal not only 
mimics the mode of ibuprofen action, it exhibits increased potency (compared with 
ibuprofen) in inhibiting COX 1 and COX 2 enzymes at equimolar concentrations. For 
instance, oleocanthal (25 µM) inhibited 41-57% of COX activity in comparison to ibuprofen 
(25 µM) which inhibited only 13-18% of COX activity.  
Moreover, Beauchamp and colleagues (Beauchamp et al., 2005) put forth the suggestion that 
chronic ingestion of small quantities of oleocanthal via EVOO consumption, may be 
responsible, in part, for the lowered prevalence of disease associated with the 
Mediterranean diet. Thus, if an olive oil consumer ingests around 50 g of EVOO a day 
containing approximately 200 μg/kg of oleocanthal, the person would ingest approximately 
10 mg/day of oleocanthal. This would equate to a relatively low (10%) equivalent dose of 
ibuprofen (recommended for adult pain relief). Chronic low doses of ibuprofen and other 
COX inhibitors such as aspirin are known to have important health benefits in the 
prevention of cancer development (e.g. colon and breast) (Garcia-Rodriguez and Huerta-
Alvarez, 2001, Harris et al., 2006) and CVD (Hennekens, 2002). Therefore, long term 
ingestion of oleocanthal via EVOO consumption may contribute to a reduction in chronic 
disease development and certainly emerging evidence supports this notion. 
Finally, it is important to note oleocanthal’s bioavailability within the body. Only one study 
has investigated this to date. A study by Garcia-Villalba et al. (Garcia-Villalba et al., 2010) 
noted that oleocanthal was readily metabolized however further studies are required to gain 
a more thorough understanding of the metabolism and bioavailability of this compound. 
6.1 Oleocanthal and neuro-degenerative disease 
Ibuprofen is known to exert beneficial effects on markers of neuro-degenerative  disease 
(Van Dam et al., 2008) and based on the similar oral irritant properties and shared anti-
inflammatory mode of action via COX inhibition, oleocanthal was investigated for potential 
neuro-protective properties. Li and collegues (Li et al., 2009) presented significant findings 
demonstrating that oleocanthal inhibits tau fibrillization in vitro by forming an adduct with 
PHF6 peptide, which is a VQIXXK motif that resides in the microtubule binding region, and 
is crucial in the formation of tau fibrils (Li and Virginia, 2006) Hyperphosphorylated tangles 
of tau are lesions that are observed in neuro-degenerative disease (i.e. Alzheimer’s disease) 
and PHF6 enables the phosphorylation of tau, thus the convalent modification of PHF6 
peptide disrupts tau-tau interaction and subsequent fibril formation (Li et al., 2009) (Figure 
4). Β-amyloid peptides (Aβ) are another type of lesion that are characteristic of Alzheimer’s 
disease (Guela et al., 1998), as Aβ derived diffusible ligands (ADDLs) are neurotoxic factors 
proposed to instigate the onset of Alzheimer’s disease (Pitt et al., 2009). Pitt and colleagues 
(2009) demonstrated that in vitro, oleocanthal alters the structure of ADDLs and augments 
antibody clearance of ADDLs, therefore protecting hippocampal neurons from ADDL 
toxicity. This data supports research showing a 40% decrease in Alzheimer’s disease in 
populations consuming a Mediterranean style diet (Scarmeas et al., 2009). 
www.intechopen.com
 
Olive Oil – Constituents, Quality, Health Properties and Bioconversions 362 
 
Fig. 4. Oleocanthal inhibits tau fibrilisation by covalently modifying the PHF-6 peptide which 
is crucial for the formation of tau fibrils. The fibrilisation of tau leads to neurofibrillary tangles 
which are inherently associated with neurodegenerative diseases such as Alzheimer’s disease.  
6.2 Oleocanthal and joint-degenerative disease 
In vitro research draws attention to oleocanthal, as a potential therapeutic compound that may 
be of interest in the quest to find suitable natural NSAIDs for the treatment of joint 
degenerative disease. Pro-inflammatory cytokines up-regulate the synthesis of cartilage to 
degrading enzymes, and stimulate nitric oxide (NO) production (Scher et al., 2007), as well as 
increase prostaglandin PGE2 production, which have all been implicated in the development 
of arthritic pain and thus joint-degenerative disease. COX enzymes are a catalyst for the 
formation of prostaglandins and have also been reported to be highly expressed in arthritic 
spine in an animal model (Procházková et al., 2009). Therefore, oleocanthal may influence 
arthritic pain through inhibition of PGE2 synthesis accompanying COX inhibition.  
NO plays an integral role in joint-degenerative disease and the stable end product of NO, 
nitrite (NO2), is significantly expressed in arthritic synovial fluid (Iacono et al., 2010). In 
osteoarthritis arthritis (OA) pathogenesis, diseased cartilage synthesizes NO spontaneously 
from diseased chrondocytes (Tung et al., 2002). NO is biosynthesized by nitric oxide 
synthase (NOS). Another form of NOS is inducible NOS (iNOS) which is largely responsible 
for the inflammatory actions of NOS (Espey et al., 2000) (Figure 5). Iacano and collegues 
(2010) have shown that oleocanthal and synthesized derivatives, decrease production of 
iNOS protein expression in LPS challenged murine chondrocytes, dose dependently, further 
highlighting the anti-inflammatory actions of oleocanthal and the pharmacological 
potential. Also, as oleocanthal mediates prostaglandin synthesis via inhibitory actions on 
COX enzymes, it is possible that oleocanthal may exert pharmacological actions in the 
treatment of both rheumatoid arthritis and osteoarthritis through COX inhibition.  
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Fig. 5. Nitric oxide (NO) derived from nitric oxide synthase (NOS), functions as a 
neurotransmitter and vasodilator, and is important in normal physiological responses. 
Inducible nitric oxide synthase (iNOS) is a third form of NOS and is not present in resting 
cells, but rather is induced by inflammatory cytokines. NO produced from iNOS promotes 
inflammation in chrondocytes and is associated with cartilage degenerative diseases such as 
osteoarthritis.  
6.3 Oleocanthal and cancer 
Recent evidence demonstrates that oleocanthal may exert therapeutic properties against the 
pathogenesis of c-Met kinase induced malignancies. Elnagar and colleagues (Elnagar et al., 
2011) have reported that oleocanthal possesses anti-proliferative effects in human breast and 
prostate cancer lines (Elnagar et al., 2011). Also Khanal and collegues (Khanal et al., 2011) 
recently showed that oleocanthal has an anti-proliferative effect and prevents tumour 
induced cell transformation in mouse epidermal JB6 Cl41cells. The mechanism of action in 
which oleocanthal achieved this was via the inhibition of extracellaullar signal-regulated 
kinases 1/2 and p90RSK phosphorylation. Furthermore, oleocanthal has also been shown to 
promote cell apoptosis by activating caspase-3 and poly-adenosine diphosphate-ribose 
polymerase, the phosphorylation of p53 (Ser15), and also induced fragmentation of DNA in 
HT-29 cells derived from human colon adenocarcinoma (Khanal et al., 2011). These findings 
suggest that oleocanthal may have potential as a therapeutic agent in the inhibition of 
carcinoma progression and supports substantial evidence that populations residing in the 
Mediterranean region have a reduced incidence of prostate, breast, lung and gastrointestinal 
cancer (Trichopoulou et al., 2000, La Vecchia, 2004, Fortes et al., 2003, Dixon et al., 2007). It is 
important to note that while there is strong evidence that oleocanthal is an effective anti-
inflammatory agent and demonstrates pharmacological characteristics in vitro, future in vivo 
studies are required to fully elucidate the efficacy of this natural NSAID. Caution is required 
when extrapolating results from a single compound out of the matrix in which it normally 
exists. Oleocanthal is one of many phenolic compounds contained in EVOO, and it is 
probable that the synergistic and interactive actions of these phenolics combined are 
responsible for the low incidence of chronic inflammation associated with EVOO intake. 
Furthermore, the bioavailability of oleocanthal needs to be firmly established in future 
research to consolidate the pharmacological potential of this compound. 
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7. Extraction, identification and quantification of oleocanthal  
The method used for the extraction, identification and quantification of oleocanthal 
described herein, is selective for oleocanthal and was developed by Beauchamp and co-
workers (Beauchamp et al., 2005). More recently, this method was adapted and involves the 
quantification of oleocanthal using an internal standard (ISTD), 3,5 dimethoxyphenol 
(Beauchamp et al., 2005, Cicerale et al., 2009b).  
The extraction of oleocanthal from the oil matrix involves liquid-liquid partitioning using 
both hexane and acetonitrile, whereby the phenolic fraction partitions into the acetonitrile 
phase. Acetonitrile is then removed and the dried down extract is dissolved in 
methanol:water and analyzed by HPLC. Separation of the oleocanthal phenolic compound 
is carried out using a HPLC system with a diode array detector set to 278 nm. A reverse 
phase-C18 column (250 mm × 4.6 mm ID, 5 μm) is used for the separation at a constant 
temperature of 25°C using the gradients listed in Table 1. A flow rate of 1 ml/min is used, 
and the injection volume is 20 μl. See Figure 6 for HPLC chromatogram. 
 
Fig. 6. HPLC chromatogram of olive oil phenolic extract containing oleocanthal and 3,5 
dimethoxyphenol (ISTD) (Cicerale et al., 2009b). 
Via mass spectrometry (6210 MSDTOF), oleocanthal is further identified under the 
following conditions: drying gas, nitrogen (N2) (7 mL-1, 350°C); nebulizer gas, N2 (15 psi); 
capillary voltage 4.0 kV; vaporizer temperature, 350°C; and cone voltage, 60 V. Figure 7 
displays the negative ion mass spectrum of oleocanthal with the characteristic [M-H]- ion at 
m/z 303.12 highlighted.  
mAU 
Time (min) 
Oleocanthal 
ISTD
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Time Gradient 
0-35 min 75% water, 25% acetonitrile 
36-55 min 90% acetonitrile, 10% methanol 
56-65 min 75% water, 25% acetonitrile 
Table 1. Mobile phase gradient for oleocanthal separation.  
 
Fig. 7. Negative ion mass spectrum of oleocanthal with the characteristic [M-H]- ion at m/z 
303.12  (Cicerale et al., 2009b). 
8. Oleocanthal concentration in olive oil and factors which may affect its 
concentration 
Oleocanthal concentration in EVOO is highly variable, ranging from as little as 0.2 mg/kg to 
as high as 498 mg/kg (Gomez-Rico et al., 2006). Such variation in oleocanthal concentration 
amongst differing EVOOs may be due to multiple factors that have the capacity to modify 
the concentration of this compound (Carrasco-Pancorbo et al., 2005). These factors include: 
method of phenolic extraction and quantification, geographic region of olive growth, olive 
tree cultivar, agricultural techniques applied to cultivate olives, olive maturity, processing of 
the olives to oil, storage of oil, and domestic heat application to oil.  
8.1 Extraction and quantification 
The analytical method used to quantify phenolics present in EVOO has an influence on the 
reported concentration and therefore is an important consideration when interpreting and 
comparing the data of such investigations (Carrasco-Pancorbo et al., 2005). Regarding the 
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analysis of oleocanthal, Beauchamp and colleagues (Beauchamp et al., 2005) in collaboration 
with Impellizzeri et al. (Impellizzeri and Lin, 2006), developed an extraction and 
quantification method specific for this compound. Utilizing this method, Impellizeri et al. 
(Impellizzeri and Lin, 2006) and Franconi et al. (Franconi et al., 2006) found the 
concentration of oleocanthal ranged between 8.3 ± 4.0 and 189.9 ± 2.7 mg/kg. An adaption of 
the Beauchamp and co-workers’ (Beauchamp et al., 2005) methodology, was also utilized in 
studies by Cicerale and colleagues (Cicerale et al., 2009a, Cicerale et al., 2009b, Cicerale et al., 
2011b, Cicerale et al., 2011a). The resultant oleocanthal concentrations in these investigations 
were similar to those found by Franconi et al. (Franconi et al., 2006) and Impellizzeri et al. 
(Impellizzeri and Lin, 2006) (53.9 ± 7.7 to 152.2 ± 10.5 mg/kg). However, a number of methods 
not specific for oleocanthal have also been used to quantify this compound and may account 
partially for the large variation in oleocanthal concentration observed (5.0 ± 0.3 – 498.0 ± 47.0 
mg/kg) (Vierhuis et al., 2001, Servili et al., 2007b, Servili et al., 2007a, Romero et al., 2002, 
Morello et al., 2004, Tovar et al., 2001, De Stefano et al., 1999, Montedoro et al., 1992, Gomez-
Alonso et al., 2003, Gomez-Rico et al., 2006, Allouche et al., 2007)  
8.2 Geographic region 
Geographic region in which olives are grown has been shown to be an important factor in 
regards to phenolic composition and concentration in general (Vinha et al., 2005, Cerretani 
et al., 2005). Beauchamp et al. (Beauchamp et al., 2005) demonstrated that EVOOs produced 
in differing countries had variable oleocanthal concentrations. For instance, EVOO 
produced in the U.S.A., contained a low concentration of oleocanthal (22.6 ± 0.6 mg/kg), 
however EVOOs produced in Italy contained some of the highest quantities of this 
compound (up to 191.8 ± 2.7 mg/kg). 
8.3 Cultivar 
Several studies have demonstrated differences between olive cultivar and oleocanthal 
concentration in the oil produced. In one study, the Coratina cultivar EVOO contained 78.2 ± 
0.5 mg/kg oleocanthal, whereas the Oliarola cultivar EVOO contained 21.0 ± 0.8 mg/kg 
oleocanthal, a 3-fold difference (De Stefano et al., 1999). In another study, EVOO produced 
from the Frantoio cultivar had an oleocanthal concentration of 43.8 ± 3.1 mg/kg, whilst EVOO 
obtained from the Coratina cultivar, contained a 2-fold higher oleocanthal content at 92.8 ± 7.8 
mg/kg (Servili et al., 2007b). A study by Franconi and colleagues (Franconi et al., 2006) also 
showed significant differences in oleocanthal concentration amongst differing olive  cultivars. 
For instance, an oleocanthal concentration of 8.3 ± 4.0 mg/kg and 53.0 ± 12.0 mg/kg in EVOOs 
produced from the Taggiasca and Seggianese cultivars respectively, was noted. 
8.4 Agricultural methods 
The concentration of phenolic compounds in EVOO is greatly affected by agricultural 
techniques used in the cultivation of olive fruit (Gomez-Rico et al., 2006, Ayton et al., 2007). 
Tovar and co-workers (Tovar et al., 2001) demonstrated that with increased irrigation applied 
to the olive tree, oleocanthal concentration decreased. For instance, in the EVOO obtained from 
the least irrigated olive trees (46 mm water per year) oleocanthal concentration was 
determined to be 50.9 ± 6.5 mg/kg. For the EVOO produced from highly irrigated olive trees 
(259 mm water per year), oleocanthal concentration was 23.1 ± 1.3 mg/kg. Gomez-Rico et al. 
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(Gomez-Rico et al., 2006) also demonstrated the negative effect of irrigation on oleocanthal 
concentration. Rain-fed olive trees produced EVOO containing higher concentrations of 
oleocanthal (229.0 ± 48.0 to 498 ± 47.0 mg/kg) compared to those that underwent the highest 
amount of irrigation (206 mm water per year), (119.0 ± 36.0 to 336.0 ± 81.0 mg/kg). Two 
additional studies (Romero et al., 2002, Servili et al., 2007a) are also in agreement with this data 
in that, they both observed a 37-38% decrease in oleocanthal concentration amongst the 
EVOOs from the highly irrigated olive trees compared to those least irrigated.  
8.5 Olive maturation  
Maturation of the olive fruit at harvest is an important predictor of the phenolic composition 
and concentration in EVOO. In regards to oleocanthal, one study found that with extended 
picking date and increased olive fruit ripeness, the concentration of oleocanthal in EVOO 
decreased by 43% (148.0 mg/kg to 84.0 mg/kg) over a short two month period (Morello et 
al., 2004). The researchers, Gomez-Rico et al. (Gomez-Rico et al., 2006) also observed a 
similar decrease of 20% and 54% in oleocanthal with increasing maturity index using two 
olive cohorts.  
8.6 Processing 
In general, the processing of olive fruit to oil has a substantial effect on the concentrations of 
phenolic compounds in EVOO (Kalua et al., 2006b, Cerretani et al., 2005, Vierhuis et al., 
2001, Romero et al., 2004, Gimeno et al., 2002). EVOO produced by the traditional processing 
method (whereby the entire olive fruit is crushed, including the stone), was found to contain 
lower quantities of oleocanthal (43.8 ± 3.1 mg/kg) compared to EVOO produced by the 
stoning method in which the olive stone is removed before crushing (54.8 ± 3.1 mg/kg). The 
researchers from this study hypothesized that the differences may be due to the increased 
peroxidase (POD) activity that tends to accompany the crushed olive stone, which has an 
oxidizing effect on oleocanthal concentration (Servili et al., 2007b). 
EVOO produced under nitrogen (N2) flushing and with use of enzymatic treatment (which 
aids cell wall degradation and thus improves phenolic extraction) (Vierhuis et al., 2001), was 
found to contain oleocanthal concentrations of 31.4 ± 1.0 mg/kg. EVOO produced with no 
added enzymes and without nitrogen (N2) flushing (therefore allowing oxygen (O2) to be 
present) was found to contain a lower amount of oleocanthal (24.8 ± 1.9 mg/kg). EVOOs 
produced with use of N2 flushing alone and enzymatic treatment alone, contained 28.4 ± 1.4 
mg/kg and 29.4 ± 0.8 mg/kg oleocanthal respectively (Vierhuis et al., 2001).  
EVOOs produced using two-phase centrifugation which uses no added water in the 
processing method, was found to contain a higher phenolic concentration compared to 
EVOOs obtained from three-phase centrifugation which utilizes a considerable amount of 
water (approximately 400 L/h) (De Stefano et al., 1999). De Stefano and et al. (De Stefano 
et al., 1999) found oleocanthal concentration in EVOO obtained from the two-phase 
centrifuge to be higher (78.2  0.5 mg/kg) than that produced from the three-phase 
method (67.3 ± 2.6 mg/kg). The addition of water in the three-phase centrifugation 
method, may have a reducing effect on the more water-soluble phenolics from the oil 
phase during processing, thus reducing the concentration of oleocanthal in the resultant 
EVOO (Cicerale et al., 2009c). 
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8.7 Storage of EVOO 
Immediately following oil extraction from the olive fruit, there is potential for the phenolic 
quality of the oil to decline, via oxidation catalysed by oxygen (O2) and light (Kalua et al., 
2006a, Morello, 2004). One study to date, has investigated the effect O2, light, and storage time 
have on oleocanthal concentration. In this study, oleocanthal concentration decreased 
somewhat (15 - 37%) over a 10-month storage period, depending on the storage conditions. 
The largest decrease was seen in EVOO stored under exposure to O2 and light (37%) and the 
smallest loss was found in the EVOO stored under O2 and light limiting conditions (15%). Oils 
stored under sole exposure to O2 or light were found to have a similar rate of oleocanthal 
degradation over the 10-month period (28% and 25% respectively) (Cicerale et al., 2011b). 
8.8 Domestic heat application 
In general, research has shown that olive oil phenolic compounds are subject to degradation 
upon the application of heat during cooking (Brenes et al., 2002, Gomez-Alonso et al., 2003). 
However, oleocanthal has demonstrated to be relatively stable upon heating when the 
EVOO contains a considerable quantity of this compound initially.  
One study found a 20% decrease in oleocanthal (96.7 ± 8.5 to 77.5 ± 2.4 mg/kg) upon 12 frying 
operations (each frying operation 10 min in length, at a temperature of 180°C) (Gomez-Alonso 
et al., 2003). Similarly, another study observed a 24% decrease (41.5 ± 0.3 to 31.4 ± 0.1 mg/kg) 
in oleocanthal after heating at 180°C for 36 hr (Allouche et al., 2007). However, for EVOO 
which naturally contained a lower quantity of oleocanthal to begin with (7.9 ± 0.5 mg/kg), 
oleocanthal degradation was substantially higher at 71%. It appears that oleocanthal possesses 
an antioxidative effect, in that oleocanthal is able to withstand heating and therefore protect 
itself to a greater degree when there is a higher concentration of it in EVOO.  
Cicerale and co-workers (Cicerale et al., 2009b) also demonstrated oleocanthal to be stable 
upon heating at high temperatures (240°C) for extended periods of time (up to 90 min). The 
authors postulated that the minimal degradation of oleocanthal may be partially due to the 
chemical structure of this compound and subsequent antioxidant activity. The antioxidant 
capacity of phenolic compounds is dependent upon the number of hydroxyl groups bonded 
to the aromatic ring (Sroka and Cisowski, 2003). When free radicals are produced through 
oxidation, phenolic compounds with a higher number of hydroxyls and therefore increased 
antioxidant capacity, quickly diminish because they react rapidly with lipid radicals and are 
therefore consumed (Gomez-Alonso et al., 2003). Oleocanthal possesses one hydroxyl group. 
Moreover, the site of bonding and mutual position of hydroxyls in the aromatic ring was 
also postulated to play a role in the antioxidant potential of phenolic compounds (Sroka and 
Cisowski, 2003, Rice-Evans et al., 1996). Rice-Evans and co-workers (Rice-Evans et al., 1996) 
reported that a hydroxyl group in the ortho position in the aromatic ring results in increased 
antioxidant capacity compared to compounds with hydroxyl groups in the meta and para 
positions. Oleocanthal contains its one hydroxyl group in the para position. These structural 
features may help in explaining why a minimal degradation of oleocanthal was observed 
(Cicerale et al., 2009c).  
9. Perspectives and future directions 
In summary, EVOO a key component of the Mediterranean diet contains a number of 
phenolics, one being oleocanthal. The unique sensory qualities and anti-inflammatory actions 
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of oleocanthal, have prompted research to further verify its therapeutic potential. Oleocanthal 
has been shown, in vitro, to exert beneficial physiological effects in terms of neuro-
degenerative disease, joint-degenerative disease and cancer. Therefore, it has been postulated 
that the long term ingestion of this compound via EVOO consumption may have significant 
health promoting action over time, thereby reducing the development of chronic disease.  
However, the studies conducted on the health promoting potential of oleocanthal have 
involved in vitro investigations and it is difficult to extrapolate data from in vitro studies to 
actual physiological benefits. In vivo research is therefore required to substantiate the in vitro 
findings. Furthermore, the bioavailability of oleocanthal has not been adequately 
investigated. To date, only one study has reported on the post-ingestive fate of oleocanthal, 
noting that it was readily metabolized however the mechanism was not investigated. The 
degree to which oleocanthal is metabolized is an important consideration when reviewing 
the health benefits associated with ingestion, and further research on this is warranted. The 
link between the perceptual aspects of oleocanthal and health benefits is the notion that 
variation in sensitivity to oleocanthal oro-pharyngeal irritation may relate to potential 
differences in sensitivity to the anti-inflammatory action of this compound and this is also 
worthy of future investigations. 
Finally, it was not the purpose of this overview to attribute the health benefits of the 
Mediterranean diet solely to one component and we did not aim to credit oleocanthal as 
being the lone therapeutic agent contained in EVOO. Other constituents of the 
Mediterranean diet and EVOO will contribute, either with independent actions, or in a 
synergistic and complementary manner to impart beneficial health effects (Lucas et al., 2011, 
Fogliano and Sacchi, 2006). However, the studies conducted to date investigating the 
pharmacological actions of oleocanthal are encouraging and show that this compound 
possesses substantial health benefiting properties. Further research will no doubt provide 
new insight into the pharmacological potential of oleocanthal and assess the role that 
oleocanthal has in the clinical treatment of chronic disease. 
10. References 
Aguilera, C. M., Mesa, M. D., Ramirez-Tortosa, M. C., Nestares, M. T., Ros, E. & Gil, A. 2004. 
Sunflower oil does not protect against LDL oxidation as virgin olive oil does in 
patients with peripheral vascular disease. Clinical Nutrition, 23, 673-681. 
Allouche, Y., Jimenez, A., Gaforio, J. J., Uceda, M. & Beltran, G. 2007. How heating affects 
extra virgin olive oil quality indexes and chemical composition. Journal of 
Agricultural and Food Chemistry, 55, 9646-9654. 
Andrewes, P., Busch, J. L., De Joode, T., Groenewegen, A. & Alexandre, H. 2003. Sensory 
properties of virgin olive oil polyphenols: identification of deacetoxy-ligstroside 
aglycon as a key contributor to pungency. Journal of Agricultural and Food Chemistry. 
Ayton, J., Mailer, R. J., Haigh, A., Tronson, D. & Conlan, D. 2007. Quality and oxidative 
stability of Australian olive oil according to harvest date and irrigation. Journal of 
Food Lipids, 14, 138-156. 
Babio, N., Bullo, M., Basora, J., Martinez-Gonzalez, M. A., Fernandez Ballart, J., Marquez-
Sandoval, F., et al. 2009. Adherence to the Mediterranean diet and risk of metabolic 
syndrome and its components. Nutrition, Metabolism and Cardiovascular Diseases, 19, 
563-570 
www.intechopen.com
 
Olive Oil – Constituents, Quality, Health Properties and Bioconversions 370 
Beauchamp, G. K., Keast, R. S., Morel, D., Lin, J., Pika, J., Han, Q., et al. 2005. 
Phytochemistry: ibuprofen-like activity in extra-virgin olive oil. Nature, 437, 45-46. 
Boland, G., Butt, I., Prasad, R., Knox, W. & Bundred, N. 2004. COX-2 expression is associated 
with an aggressive phenotype in ductal carcinoma in situ. British Journal of Cancer, 
90, 423-429. 
Brenes, M., Garcia, A., Dobarganes, M. C., Velasco, J. & Romero, C. 2002. Influence of 
thermal treatments simulating cooking processes on the polyphenol content in 
virgin olive oil. Journal of Agricultural and Food Chemistry, 50, 5962-5967. 
Carrasco-Pancorbo, A., Cerretani, L., Bendini, A., Segura-Carretero, A., Gallina-Toschi, T. & 
Fernandez-Gutierez, A. 2005. Analytical determination of polyphenols in olive oils. 
Journal of Separation Science, 28, 837-858. 
Cerretani, L., Bendini, A., Rotondi, A., Lercker, G. & Toschi, T. G. 2005. Analytical 
comparison of monovarietal virgin olive oils obtained by both a continuous 
industrial plant and low-scale mill. European Journal of Lipid Science and Technology, 
107, 93-100. 
Chenevard, R., Hurlimann, D., Bechir, M., Enseleit, F., Spieker, L., Hermann, M., et al. 2003. 
Selective COX-2 inhibition improves endothelial function in coronary artery 
disease. Circulation, 10000051r. 
Cicerale, S., Breslin, P. A. S., Beauchamp, G. K. & Keast, R. S. J. 2009a. Sensory 
characterization of the irritant properties of oleocanthal, a natural anti-
inflammatory agent in extra virgin olive oils. Chemical Senses, 34 333-339. 
Cicerale, S., Conlan, X. A., Barnett, N. W. & Keast, R. S. 2011a. The concentration of 
oleocanthal in olive oil waste. Natural Product Research, 25, 542-8. 
Cicerale, S., Conlan, X. A., Barnett, N. W. & Keast, R. S. J. 2011b. Storage of extra virgin olive 
oil and its effect on the biological activity and concentration of oleocanthal Food 
Research International, doi:10.1016/j.foodres.2011.03.046  
Cicerale, S., Conlan, X. A., Barnett, N. W., Sinclair, A. J. & Keast, R. S. 2009b. Influence of 
heat on biological activity and concentration of oleocanthal- a natural anti-
inflammatory agent in virgin olive oil. Journal of Agricultural and Food Chemistry, 57, 
1326-1330. 
Cicerale, S., Conlan, X. A., Sinclair, A. J. & Keast, R. S. J. 2009c. Chemistry and health of olive 
oil phenolics. Critical Reviews in Food Science and Nutrition, 49, 218-236. 
Cicerale, S., Lucas, L. & Keast, R. 2010. Biological activities of phenolic compounds present 
in virgin olive oil. International Journal of Molecular Sciences, 11, 458-79. 
Corona, G., Spencer, J. P. E. & Dessi, M. A. 2009. Extra virgin olive oil phenolics: absorption, 
metabolism, and biological activities in the GI tract. Toxicology and Industrial Health, 
25, 285-293. 
Dai, J., Miller, A. H., Bremner, D., Goldberg, J., Jones, L., Shallenberger, L., et al. 2009. 
Adherence to the Mediterranean diet is inversely associated with circulating 
interleukin-6 among middle-aged men. A twin study. Circulation, 117, 169-175. 
De Stefano, G., Piacquadio, P., Servili, M., Di Giovacchino, L. & Sciancalepore, V. 1999. 
Effect of extraction systems on the phenolic composition of virgin olive oils. Lipid-
Fett, 101, 328-332. 
Dixon, B. L., Subar, A. F., Peters, U., Weissfeld, J. L., Bresalier, R. S., Risch, A., et al. 2007. 
Adherence to the USDA food guide, DASH eating plan, and Mediterranean dietary 
pattern reduces risk of colorectal adenoma. Journal of Nutrition, 137, 2443-2450. 
Elnagar, A., Sylvester, P. & El Sayed, K. 2011. -)-Oleocanthal as a c-Met Inhibitor for the 
Control of Metastatic Breast and Prostate Cancers. Planta medica. Vol- 77, pages- 
1013-1019. 
www.intechopen.com
 
Oleocanthal: A Naturally Occurring Anti-Inflammatory Agent in Virgin Olive Oil 371 
Espey, M. G., Miranda, K. M., Feelisch, M., Fukuto, J., Grisham, M. B., Vitek, M. P., et al. 
2000. Mechanisms of cell death governed by the balance between nitrosative and 
oxidative stress. Annals of the New York Academy of Science, 899, 209-21. 
Estruch, R., Martinez-Gonzalez, M. A., Corella, D., Salas-Salvado, J., Ruiz-Gutierrez, V., Covas, 
M. I., et al. 2006. Effects of a Mediterranean-style diet on cardiovascular risk factors: a 
randomized trial. Annals of Internal Medicine, 145, 1-11. 
Fogliano, V. & Sacchi, R. 2006. Oleocanthal in olive oil: between myth and reality. Molecular 
Nutrition & Food Research, 50, 5-6. 
Fortes, C., Forastiere, F., Farchi, S., Mallone, S., Trequattrinni, T., Anatra, F., et al. 2003. The 
protective effect of the Mediterranean diet on lung cancer. Nutrition and Cancer, 46, 
30-37. 
Fragopoulou, E., Panagiotakos, D. B., Pitsavos, C., Tampourlou, M., Chrysohoou, C., 
Nomikos, T., et al. 2010. The association between adherence to the Mediterranean 
diet and adiponectin levels among healthy adults: the ATTICA study. The Journal of 
Nutritional Biochemistry, 21, 285-289. 
Franconi, F., Coinu, R., Carta, S., Urgeghe, P. P., Ieri, F., Mulinacci, N., et al. 2006. 
Antioxidant effect of two virgin olive oils depends on the concentration and 
composition of minor polar compounds. Journal of Agricultural and Food Chemistry, 
54, 3121-3125. 
Fraser, A., Abel, R., Lawlor, D. A., Fraser, D. & Elhayany, A. 2008. A modified 
Medieterranean diet is associated with the greatest reduction in alanine 
aminotransferase levels in obese type 2 diabetes patients: results of a quasi-
randomised controlled trial. Diabetologia, 51, 1616-1622. 
Fung, T. T., Rexrode, K. M., Mantzoros, C. S., Manson, J. E., Willett, W. C. & Hu, F. B. 2009. 
Mediterranean diet and incidence of and mortality from coronary heart disease and 
stroke in women. Circulation, 119, 1093-1100. 
Garcia-Rodriguez, L. A. & Huerta-Alvarez, C. 2001. Reduced risk of colorectal cancer among 
long-term users of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs. 
Epidemiology, 12, 88-93. 
Garcia-Villalba, R., Carrasco-Pancorbo, A., Nevedomskaya, E., Mayboroda, O. A., Deelder, 
A. M., Segura-Carretero, A., et al. 2010. Exploratory analysis of human urine by Lc-
Esi-Tof MS after high intake of olive oil: understanding the metabolism of 
polyphenols. Analytical and Bioanalytical Chemistry, 398, 463-75. 
Gimeno, E., Castellote, A. I., Lamuela-Raventos, R. M., De La Torre, M. C. & Lopez-Sabater, 
M. C. 2002. The effects of harvest and extraction methods on the antioxidant 
content (phenolics, alpha-tocopherol, and beta-carotene) in virgin olive oil. Food 
Chemistry, 78, 207-211. 
Gomez-Alonso, S., Fregapane, G., Salvador, M. D. & Gordon, M. H. 2003. Changes in 
phenolic composition and antioxidant activity of virgin olive oil during frying. 
Journal of Agricultural and Food Chemistry, 51, 667-672. 
GOMEZ-RICO, A., SALVADOR, M. D., LA GRECA, M. & FREGAPANE, G. 2006. Phenolic 
and volatile compounds of extra virgin olive oil (Olea europaea L. Cv. Cornicabra) 
with regard to fruit ripening and irrigation management. Journal of Agricultural and 
Food Chemistry, 54, 7130-7136. 
Guela, C., Wu, C., Saroff, D., Lorenzo, A., Yuan, M. & Yankner, B. 1998. Aging renders the 
brain vulnerable to amyloid -protein neurotoxicity. Nature medicine, 4, 827-831. 
Hansen, J. L., Reed, D. R., Wright, M. J., Martin, N. G. & Breslin, P. A. 2006. Heritability and 
genetic covariation of sensitivity to PROP, SOA, quinine HCl, and caffeine. 
Chemical Senses, 31, 403-413. 
www.intechopen.com
 
Olive Oil – Constituents, Quality, Health Properties and Bioconversions 372 
Harper, C. R., Edwards, M. C. & Jacobson, T. A. 2006. Flaxseed oil supplementation does not 
affect plasma lipoprotein concentration or particle size in human subjects. Journal of 
Nutrition, 136, 2844-2848. 
Harris, R. E., Beebe-Donk, J. & Alshafie, G. A. 2006. Reduction in the risk of human breast 
cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer, 6, 27. 
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G., et al. 
2003. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results 
from the Women's Health Initiative. Cancer Research, 63, 6096-6101. 
Hayes, J. E., Wallace, M. R., Knopik, V. S., Herbstman, D. M., Bartoshuk, L. M. & Duffy, V. B. 
2011. Allelic Variation in TAS2R Bitter Receptor Genes Associates with Variation in 
Sensations from and Ingestive Behaviors toward Common Bitter Beverages in 
Adults. Chemical Senses, 36, 311. 
Hennekens, C. H. 2002. Update on aspirin in the treatment and prevention of cardiovascular 
disease. American Journal of Managed Care, 8, 691S-700S. 
Hu, F. B. 2003. The Mediterranean diet and mortality--olive oil and beyond. New England 
Journal of Medicine, 348, 2595-2596. 
Iacono, A., Gómez, R., Sperry, J., Conde, J., Bianco, G., Meli, R., et al. 2010. Effect of 
oleocanthal and its derivatives on inflammatory response induced by LPS in 
chondrocyte cell line. Arthritis & Rheumatism. Vol- 62, pages- 1675-1682. 
Impellizzeri, J. & Lin, J. 2006. A simple high-performance liquid chromatography method 
for the determination of throat-burning oleocanthal with probated 
antiinflammatory activity in extra virgin olive oils. Journal of Agricultural and Food 
Chemistry, 54, 3204-3208. 
Kalua, C. M., Bedgood, D. R., Bishop, A. G. & Prenzler, P. 2006a. Discrimination of storage 
conditions and freshness in virgin olive oil. Journal of Agricultural and  Food 
Chemistry, 54, 7144-7151. 
Kalua, C. M., Bedgood, D. R., Jr., Bishop, A. G. & Prenzler, P. D. 2006b. Changes in volatile 
and phenolic compounds with malaxation time and temperature during virgin 
olive oil production. Journal of Agricultural and Food Chemistry, 54, 7641-7651. 
Keys, A. 1970. Coronary heart disease in seven countries. Circulation, 42, 1-211. Vol- 240, 
pages- 189-197. 
Khanal, P., Oh, W. K., Yun, H. J., Namgoong, G. M., Ahn, S. G., Kwon, S. M., et al. 2011. p-
HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated 
protein kinase to inhibit carcinogenesis. Carcinogenesis, 32, 545. 
Kok, F. J. & Kromhout, D. 2004. Atherosclerosis--epidemiological studies on the health 
effects of a Mediterranean diet. European Journal of Nutrition, 43 Suppl 1, 1-5. 
La Vecchia, C. 2004. Mediterranean diet and cancer. Public Health Nutrition, 7, 965-968. 
Li, W., Sperry, J. B., Crowe, A., Trojanowki, J. Q., Smith, A. B. & Lee, V. M. Y. 2009. 
Inhibition of tau fibrillization by oleocanthal via reaction with amino groups of tau. 
Journal of Neurochemistry, 110, 1339-1351. 
Li, W. & Virginia, M. Y. L. 2006. Characterization of two VQIXXK motifs for tau fibrillization 
in vitro. Biochemistry, 45, 15692-15701. 
López-Miranda, J., Pérez-Jiménez, F., Ros, E., De Caterina, R., Badimón, L., Covas, M., et al. 
2010. Olive oil and health: summary of the II international conference on olive oil 
and health consensus report, Jaén and Córdoba (Spain) 2008. Nutrition, Metabolism 
and Cardiovascular Diseases, 20, 284-294. 
Lucas, L., Russell, A. & Keast, R. 2011. Molecular Mechanisms of Inflammation. Anti-
Inflammatory Benefits of Virgin Olive Oil and the Phenolic Compound 
Oleocanthal. Current Pharmaceutical Design, 17, 754-768. 
www.intechopen.com
 
Oleocanthal: A Naturally Occurring Anti-Inflammatory Agent in Virgin Olive Oil 373 
Martinez-Gonzalez, M. A., De La Fuente-Arrillaga, C., Nunez-Cordoba, J. M., Basterra-
Gortari, F. J., Beunza, J. J., Vazquez, Z., et al. 2008. Adherence to Mediterranean diet 
and risk of developing diabetes: prospective cohort study. British Medical Journal, 
336, 1348-1351. 
Montedoro, G. & Servili, M. 1993. Simple and hydrolyzable compounds in virgin olive oil. 
Spectroscopic characterizations of the secoiridoid derivatives. Journal of Agricultural 
and Food Chemistry, 41, 2228-2234. 
Montedoro, G., Servili, M., Baldioli, M. & Miniati, E. 1992. Simple and Hydrolyzable 
phenolic compounds in virgin olive oil. 1. Their extraction, separation, and 
quantitative and semiquantitative evaluation by HPLC. Journal of Agricultural and 
Food Chemistry, 40, 1571-1576. 
Morello, J. R. 2004. Changes in commercial virgin olive oil (cv Arbequina) during storage, 
with special emphasis on the phenolic fraction. Food Chemistry, 85, 357-364. 
Morello, J. R., Romero, M. P. & Motilva, M. J. 2004. Effect of the maturation process of the 
olive fruit on the phenolic fraction of drupes and oils from Arbequina, Farga, and 
Morrut cultivars. Journal of Agricultural and  Food Chemistry, 52, 6002-6009. 
Panagiotakos, D. B., Dimakopoulou, K., Katsouyanni, K., Bellander, T., Grau, M., Koenig, W., 
et al. 2009. Mediterranean diet and inflammatory response in myocardial infarction 
survivors. International Journal of Epidemiology, 38, 856. 
Peyrot Des Gachons, C., Uchida, K., Bryant, B., Shima, A., Sperry, J. B., Dankulich-
Nagrudny, L., et al. 2011. Unusual Pungency from Extra-Virgin Olive Oil Is 
Attributable to Restricted Spatial Expression of the Receptor of Oleocanthal. The 
Journal of Neuroscience, 31, 999. 
Pitsavos, C., Panagiotakos, D. B., Tzima, N., Chrysohoou, C., Economou, M., Zampelas, A., 
et al. 2005. Adherence to the Mediterranean diet is associated with total antioxidant 
capacity in healthy adults: the ATTICA study. American Journal of Clinical Nutrition, 
82, 694-699. 
Pitt, J., Roth, W., Lacor, P., Blankenship, M., Velasco, P., De Felice, F., et al. 2009. 
Alzheimer's-associated A-beta oligomers show altered structure, immunoreactivity 
and synaptotoxicity with low doses of oleocanthal. Toxicology and Applied 
Pharmacology, doi:10.1016/j.taap.2009.07.018. 
Procházková, M., Zanvit, P., Doležal, T., Prokešová, L. & Kršiak, M. 2009. Increased gene 
expression and production of spinal cyclooxygenase 1 and 2 during experimental 
osteoarthritis pain. Physiological research, 58, 419-425. 
Rice-Evans, C. A., Miller, N. J. & Paganga, G. 1996. Structure-antioxidant activity 
relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine, 20, 
933-956. 
Ristimäki, A., Sivula, A., Lundin, J., Lundin, M., Salminen, T., Haglund, C., et al. 2002. 
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. 
Cancer Research, 62, 632. 
Romero, C., Brenes, M., Yousfi, K., Garcia, P., Garcia, A. & Garrido, A. 2004. Effect of 
cultivar and processing method on the contents of polyphenols in table olives. 
Journal of Agricultural and Food Chemistry, 52, 479-484. 
Romero, M. P., Tovar, M. J., Girona, J. & Motilva, M. J. 2002. Changes in the HPLC phenolic 
profile of virgin olive oil from young trees (Olea europaea L. Cv. Arbequina) 
grown under different deficit irrigation strategies. Journal of Agricultural and Food 
Chemistry, 50, 5349-5354. 
www.intechopen.com
 
Olive Oil – Constituents, Quality, Health Properties and Bioconversions 374 
Scarmeas, N., Luchsinger, J. A., Schupf, N., Brickman, A. M., Cosentino, S., Tang, M. X., et al. 
2009. Physical activity, diet, and risk of Alzheimer disease. Journal of American 
Medical Association, 302, 627-637. 
Scher, J., Pillinger, M. & Abramson, S. 2007. Nitric oxide synthases and osteoarthritis. 
Current Rheumatology Reports, 9, 9-15. 
Servili, M., Esposto, S., Londolini, E., Selvaggini, R., Taticchi, A., Urbani, S., et al. 2007a. 
Irrigation effects on quality, phenolic composition, and selected volatiles of virgin 
olive oils Cv. Leccino. Journal of Agricultural and  Food Chemistry, 55, 6609-6618. 
Servili, M., Taticchi, A., Esposto, S., Urbani, S., Selvaggini, R. & Montedoro, G. 2007b. Effect of 
olive stoning on the volatile and phenolic composition of virgin olive oil. Journal of 
Agricultural and Food Chemistry, 55, 7028-7035. 
Sroka, Z. & Cisowski, W. 2003. Hydrogen peroxide scavenging, antioxidant and anti-radical 
activity of some phenolic acids. Food and Chemical Toxicology, 41, 753-758. 
Stark, A. H. & Madar, Z. 2002. Olive oil as a functional food: epidemiology and nutritional 
approaches. Nutrition Reviews, 60, 170-176. 
Subbaramaiah, K., Norton, L., Gerald, W. & Dannenberg, A. J. 2002. Cyclooxygenase-2 is 
overexpressed in HER-2/neu-positive breast cancer. Journal of Biological Chemistry, 
277, 18649 - 18657. 
Tortosa, A., Bes-Rastrollo, M., Sanchez-Villegas, A., Basterra-Gortari, F. J., Nunez-Cordoba, 
J. M. & Martinez-Gonzalez, M. A. 2007. Mediterranean diet inversely associated 
with the incidence of metabolic syndrome. Diabetes Care, 30, 2957-2959. 
Tovar, M. J., Motilva, M. J. & Romero, M. P. 2001. Changes in the phenolic composition of 
virgin olive oil from young trees (Olea europaea L. cv. Arbequina) grown under 
linear irrigation strategies. Journal of Agricultural and Food Chemistry, 49, 5502-5508. 
Trichopoulou, A., Lagiou, P., Kuper, H. & Trichopoulos, D. 2000. Cancer and Mediterranean 
dietary traditions. Cancer Epidemiology, Biomarkers and Prevention, 9, 869-873. 
Trichopoulou, A., Orfanos, P., Norat, T., Bueno-De-Mesquita, B., Ocke, M. C., Peeters, P. H., 
et al. 2005. Modified Mediterranean diet and survival: EPIC-elderly prospective 
cohort study. British Medical Journal, 330, 991-998. 
Tung, J., Venta, P. & Caron, J. 2002. Inducible nitric oxide expression in equine articular 
chondrocytes: effects of antiinflammatory compounds. Osteoarthritis and Cartilage, 
10, 5-12. 
Van Dam, D., Coen, K. & De Deyn, P. 2008. Ibuprofen modifies cognitive disease 
progression in an Alzheimer's mouse model. Journal of Psychopharmacology. Vol- 24, 
pages- 383-388. 
Vierhuis, E., Servili, M., Baldioli, M., Schols, H. A., Voragen, A. G. & Montedoro, G. F. 2001. 
Effect of enzyme treatment during mechanical extraction of olive oil on phenolic 
compounds and polysaccharides. Journal of Agricultural and Food Chemistry, 49, 
1218-1223. 
Vinha, A. F., Ferreres, F., Silva, B. M., Valentao, P., Goncalves, A., Pereira, J. A., et al. 2005. 
Phenolic profiles of Portuguese olive fruits (Olea europaea L.): Influences of 
cultivar and geographical origin. Food Chemistry, 89, 561-568. 
Visioli, F., Bogani, P., Grande, S. & Galli, C. 2005. Mediterranean food and health: building 
human evidence. Journal of Physiology and Pharmacology, 56 Suppl 1, 37-49. 
www.intechopen.com
Olive Oil - Constituents, Quality, Health Properties and
Bioconversions
Edited by Dr. Dimitrios Boskou
ISBN 978-953-307-921-9
Hard cover, 510 pages
Publisher InTech
Published online 01, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
The health-promoting effects attributed to olive oil, and the development of the olive oil industry have
intensified the quest for new information, stimulating wide areas of research. This book is a source of recently
accumulated information. It covers a broad range of topics from chemistry, technology, and quality
assessment, to bioavailability and function of important molecules, recovery of bioactive compounds,
preparation of olive oil-based functional products, and identification of novel pharmacological targets for the
prevention and treatment of certain diseases.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
S. Cicerale, L. J. Lucas and R. S. J. Keast (2012). Oleocanthal: A Naturally Occurring Anti-Inflammatory Agent
in Virgin Olive Oil, Olive Oil - Constituents, Quality, Health Properties and Bioconversions, Dr. Dimitrios Boskou
(Ed.), ISBN: 978-953-307-921-9, InTech, Available from: http://www.intechopen.com/books/olive-oil-
constituents-quality-health-properties-and-bioconversions/oleocanthal-a-naturally-occurring-anti-inflammatory-
agent-in-virgin-olive-oil
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
